FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35836311000001109: Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110013701000001112 Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110013801000001115 Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has specific active ingredient Esketamine hydrochloride true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Esketamine false Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Esketamine hydrochloride 50mg/2ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has specific active ingredient Esketamine hydrochloride false Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Is a Vesierra true Inferred relationship Existential restriction modifier
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Esketamine false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) 10 ampoule Has AMP True Vesierra 50mg/2ml solution for injection ampoules (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start